Shanghai Jiaoda Onlly Co.,Ltd (SHA:600530)
4.870
-0.190 (-3.75%)
Nov 13, 2026, 3:00 PM CST
SHA:600530 Revenue
Shanghai Jiaoda Onlly Co.,Ltd had revenue of 74.92M CNY in the quarter ending September 30, 2026, with 1.67% growth. This brings the company's total for the last twelve months to 304.56M, down -2.62% year-over-year. In the year 2025, Shanghai Jiaoda Onlly Co.,Ltd had annual revenue of 314.12M, down -3.40%. That makes Shanghai Jiaoda Onlly Co.,Ltd the 28,614th largest company in the world by revenue and 4,871st in China.
Revenue (ttm)
304.56M
Revenue Growth
-2.62%
P/S Ratio
12.54
Revenue / Employee
324.35K
Employees
939
Market Cap
3.77B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full SHA:600530 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 314.12M | -11.07M | -3.40% |
| Dec 31, 2024 | 325.18M | 28.85M | 9.74% |
| Dec 31, 2023 | 296.33M | -80.82M | -21.43% |
| Dec 31, 2022 | 377.15M | 14.57M | 4.02% |
| Dec 31, 2021 | 362.58M | 29.88M | 8.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Jinling Pharmaceutical Company | 3.17B |
| Jiangsu Lianhuan Pharmaceutical | 2.96B |
| Nanjing Well Pharmaceutical Group | 1.40B |
| Tianjin Lisheng Pharmaceutical | 1.27B |
| Hunan Hansen Pharmaceutical | 1.01B |
| LanZhou Foci Pharmaceutical | 941.70M |
| Nanjing Hicin Pharmaceutical | 814.80M |
| Zhongzhu Healthcare Holding Co.,Ltd | 535.62M |